Bayer AG (BAYGn.DE)
82.98EUR
2:37pm BST
€2.20 (+2.72%)
€80.78
€82.00
€83.58
€81.61
2,877,100
3,345,857
€118.04
€75.50
Latest Key Developments (Source: Significant Developments)
Bayer: Leo Pharma Buys Bayer's Prescription Dermatology Unit
July 31 (Reuters) - BAYER AG
Bayer Receives Positive CHMP Opinion For Rivaroxaban For Patients With Coronary Or Peripheral Artery Disease
July 27 (Reuters) - Bayer AG
Bayer Reaffirms Safety Profile Of Essure
July 26 (Reuters) - :BAYER REAFFIRMS SAFETY PROFILE OF ESSURE.NO RELIABLE SCIENTIFIC EVIDENCE TO SUGGEST THAT ANY NEW SAFETY CONCERNS EXIST WITH ESSURE. Full Article
FDA Provides Statement On Bayer's Voluntary Recall Of Essure Permanent Birth Control Device
July 20 (Reuters) - U.S. Food & Drug Administration::U.S. FDA SAYS NOTIFIED BY BAYER THAT THE ESSURE PERMANENT BIRTH CONTROL DEVICE WILL NO LONGER BE SOLD OR DISTRIBUTED AFTER DEC 31.U.S. FDA SAYS EXPECTS BAYER TO MEET ITS POSTMARKET OBLIGATIONS CONCERNING THE ESSURE PERMANENT BIRTH CONTROL DEVICE.U.S. FDA SAYS WILL CONTINUE TO MONITOR ADVERSE EVENTS REPORTED TO FDA'S DATABASE & OTHER DATA SOURCES REGARDING ESSURE PERMANENT BIRTH CONTROL DEVICE.U.S. FDA SAYS RESTRICTION ON SALE AND DISTRIBUTION OF ESSURE PERMANENT BIRTH CONTROL DEVICE WILL REMAIN IN PLACE.U.S. FDA SAYS "FOR WOMEN WHO HAVE RECEIVED AN ESSURE IMPLANT, THE POSTMARKET SAFETY OF ESSURE WILL CONTINUE TO BE A TOP PRIORITY FOR THE FDA". Full Article
Bayer To Voluntarily Discontinue U.S. Sales Of Essure At End Of 2018
July 20 (Reuters) - Bayer AG
SA's Competition Tribunal Conditionally Approves BASF SE Acquisition Of Divestment Business Of Bayer AG
July 18 (Reuters) - SA'S COMPETITION TRIBUNAL::CONDITIONALLY APPROVED MERGER ON GERMAN-BASED AGROCHEMICAL COMPANY BASF SE IS TO ACQUIRE DIVESTMENT BUSINESS OF BAYER AG. Full Article
Endo, Bayer defeat Custopharm appeal over Aveed patents
July 13 (Reuters) - Endo, bayer defeat appeal by custopharm over validity of patents related to testosterone replacement therapy aveed -- u.s. Court ruling:. Full Article
German Chemicals Industry Says Revenues Up 5.5 Pct In H1
July 12 (Reuters) - LANXESS AG
SA's Competition Commission Recommends Competition Tribunal On Zaad's Proposed Deal With Hygrotech
July 9 (Reuters) - South Africa's Competition Commission::RECOMMENDED TO COMPETITION TRIBUNAL THAT ZAAD'S PROPOSED DEAL WITH HYGROTECH BE APPROVED WITHOUT CONDITIONS.RECOMMENDED THAT BASF SE GERMANY'S DEAL TO BUY DIVESTMENT BUSINESS OF BAYER BE APPROVED WITHOUT CONDITIONS. Full Article
Bayer Backs Monsanto Takeover With EUR5 Bln Bond Issue
June 19 (Reuters) - Bayer AG
Bayer says dicamba report not new
FRANKFURT Bayer said on Friday that a German media report this week that U.S. farmers were suing its Monsanto unit over crop damage caused by weedkiller dicamba does not represent a new development.
Earnings vs. 
Estimates